AM Technology joins EU funded flow chemistry project

Published: 21-Sep-2009
Manufacturing Sustainability Research & Development

AM Technology, a UK developer of chemical reactors and reactor control systems, has joined an EU-funded project that seeks to develop flow processes for the industrial synthesis of pharmaceutical compounds.


AM Technology, a UK developer of chemical reactors and reactor control systems, has joined an EU-funded project that seeks to develop flow processes for the industrial synthesis of pharmaceutical compounds.

AM Technology, based in Runcorn, Cheshire, says greater use of flow chemistry within the industry will bring substantial benefits in terms of reduced manufacturing costs, lower carbon footprints and less pollution. However, developing flow chemistry techniques for industrial pharmaceutical processes faces a variety of technical and regulatory hurdles and the Pharmagen project will use a multi disciplinary approach to tackle them.

The two-year Pharmagen project is being coordinated by Serichim of Italy and has other five partners. It has funding from the EU Commission DG Research within the VII Framework Programme for Research and Development.

AM Technology says its patented Coflore ACR (Agitated Cell Reactor) is the first modular multi stage CSTR and represents a breakthrough in flow reactor design. It features dynamic mixers combined with multiple reaction stages and, the company says, offers outstanding mixing, plug flow and versatility.

  • Companies:
  • AM Technology
See more

You may also like

Manufacturing

Improved reaction vessel switching in flow chemistry

Read more
"For users to be able to swap reaction vessels quickly and easily is a significant benefit, hence deciding to integrate Asynt ReactoMate ATOM into our Coflore peripheral equipment solutions"

Trending Articles

  1. Olon releases its annual ESG report The Italian Group, leading international API supplier, presents the 2023 sustainability report and confirms the sustainability journey toward energy transition, investments in alternative energy sources, social and economic involvement and support for the communities in which it operates
  2. IMed supports K2 medical systems in their EU MDR transition Consultancy firm helps K2 navigate the complex regulatory process to achieve Article 97 compliance
  3. CDMO GBI Biomanufacturing expands US drug product services with aseptic fill/finish capabilities Its Florida site will now be able to support biopharma clients from clinical trials to commercialisation with a dual manual/automated fill/finish approach
  4. Sartorius Stedim Biotech supports bioprocess development with new Innovation Centre The Massachusetts, US-based Centre for Bioprocess Innovation is a collaborative space designed to develop and optimise biomanufacturing processes

Upcoming event

CPhI India

26–28 November 2024 | Online Conference & Networking | Delhi, India See all

You may also like

Manufacturing

Improved reaction vessel switching in flow chemistry

"For users to be able to swap reaction vessels quickly and easily is a significant benefit, hence deciding to integrate Asynt ReactoMate ATOM into our Coflore peripheral equipment solutions"
Manufacturing

AM Technology secures £4.1m investment

Development of new chemical reactor will have a significant impact on major UK supply chains
You need to be a subscriber to read this article.
Click here to find out more.
Ingredients

Let enzymes do the work

The use of enzyme catalysts has had a real impact on the synthesis of pharmaceutical ingredients, making it possible to improve some syntheses dramatically and even make some molecules that would otherwise be either impossible or impractical to synthesise. The use of flow reactors in biocatalysis faces challenges arising from the heterogeneous slurry nature of the reaction mixture and problems with gas and liquid handling. But research is being carried out into continuous manufacturing methods for biocatalytic reactions.
Manufacturing

Biochemist Project to develop flow process techniques for biomanufacturing

Three UK technology companies, C‐Tech Innovation, Ingenza and AM Technology are collaborating on a
Manufacturing

New flow reactor tackles scale up problems

<p>AM Technology, based in Runcorn, Cheshire, has developed a new flow reactor which it says is flexible and capable of handling problem fluids at low throughputs.</p>
Manufacturing

Ashe Morris in collaboration to co-develop glass-lined Coflux reactors

<p>Two process manufacturing companies based in the UK and Germany have teamed up to develop batch reactors with improved performance.</p><p>Ashe Morris, a specialist in the development of process equipment for the chemical and pharmaceutical industries based in Runcorn, UK has signed a collaboration agreement with Robbins & Myers Process Solutions Group (Pfaudler) for the development Coflux glass lined batch reactors.</p><p>The product uses a variable geometry heating/cooling jacket, which offers faster and more stable temperature control, the ability to set the jacket height to suit the level in the vessel and improved energy efficiency. It also provides very sensitive process heat data - serving as a robust and versatile Process Analytical Technology (PAT) tool. Batch reactor users can also improve the economics of batch process such as chemical reactions and crystallisation through real time analytical data. </p><p>As part of the collaboration, Ashe Morris and Pfaudler, a sp
Manufacturing

Ashe Morris enters into collaborative development with Pfaudler

<p>Engineering design and technology licensing company Ashe Morris has entered into a collaborative development agreement with Pfaudler, a unit of Robbins & Myers, to develop designs for industrial scale glass-lined reactors that incorporate Ashe Morris&quot; Coflux technology. </p>
Subscribe now